论文部分内容阅读
Patients who are infected with hepatitis C virus （HCV）and also have advanced fibrosis or cirrhosis have beenrecognized as ＂difficult-to-treat＂ patients during an erawhen peginterferon and ribavirin combination therapy isthe standard of care. Recent guidel